LENZ Therapeutics Operating Income

LENZ Therapeutics (LENZ) currently reports a operating income of $-150M as of September 2026. That compares with $-68M in the prior-year period — down 120.5% year over year. Use the charts on this page to explore LENZ Therapeutics's operating income history and peer comparisons.

LENZ Therapeutics's operating income decreased from $-68M to $-150M — a 120.5% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LENZ Therapeutics reported $-150M in operating income as of September 2026. That compares with $-68M in the prior-year period — down 120.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-150M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LENZ Therapeutics, and consider following LENZ for alerts when major investors trade the stock.

LENZ Therapeutics is classified in the Healthcare sector. On operating income, it currently shows $-150M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LENZ with unrelated industries.